MediPal Holdings Corporation
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drug… Read more
MediPal Holdings Corporation (MEPDF) - Net Assets
Latest net assets as of September 2025: $766.14 Billion USD
Based on the latest financial reports, MediPal Holdings Corporation (MEPDF) has net assets worth $766.14 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.91 Trillion) and total liabilities ($1.14 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $766.14 Billion |
| % of Total Assets | 40.16% |
| Annual Growth Rate | 7.82% |
| 5-Year Change | 18.63% |
| 10-Year Change | 55.21% |
| Growth Volatility | 8.9 |
MediPal Holdings Corporation - Net Assets Trend (2005–2025)
This chart illustrates how MediPal Holdings Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MediPal Holdings Corporation (2005–2025)
The table below shows the annual net assets of MediPal Holdings Corporation from 2005 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $757.95 Billion | +2.90% |
| 2024-03-31 | $736.61 Billion | +7.06% |
| 2023-03-31 | $688.05 Billion | +6.00% |
| 2022-03-31 | $649.09 Billion | +1.59% |
| 2021-03-31 | $638.93 Billion | +5.19% |
| 2020-03-31 | $607.42 Billion | +2.46% |
| 2019-03-31 | $592.85 Billion | +3.53% |
| 2018-03-31 | $572.65 Billion | +9.88% |
| 2017-03-31 | $521.16 Billion | +6.72% |
| 2016-03-31 | $488.33 Billion | +6.71% |
| 2015-03-31 | $457.60 Billion | +12.30% |
| 2014-03-31 | $407.48 Billion | +6.70% |
| 2013-03-31 | $381.89 Billion | +7.77% |
| 2012-03-31 | $354.34 Billion | +3.92% |
| 2011-03-31 | $340.98 Billion | +3.02% |
| 2010-03-31 | $330.99 Billion | +12.39% |
| 2009-03-31 | $294.50 Billion | +1.31% |
| 2008-03-31 | $290.69 Billion | +11.33% |
| 2007-03-31 | $261.11 Billion | +7.71% |
| 2006-03-31 | $242.41 Billion | +44.20% |
| 2005-03-31 | $168.10 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to MediPal Holdings Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 368.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $463.07 Billion | 74.74% |
| Common Stock | $22.40 Billion | 3.62% |
| Other Comprehensive Income | $56.28 Billion | 9.08% |
| Other Components | $77.82 Billion | 12.56% |
| Total Equity | $619.56 Billion | 100.00% |
MediPal Holdings Corporation Competitors by Market Cap
The table below lists competitors of MediPal Holdings Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Constellium Nv
NYSE:CSTM
|
$3.01 Billion |
|
Tube Investments of India Limited
NSE:TIINDIA
|
$3.01 Billion |
|
Far Eastern New Century Corp
TW:1402
|
$3.01 Billion |
|
Getinge AB ser. B
ST:GETI-B
|
$3.01 Billion |
|
Genting Berhad
PINK:GEBHY
|
$3.00 Billion |
|
Western Union Co
NYSE:WU
|
$3.00 Billion |
|
Inner Mongolia Yuan Xing Energy Co Ltd
SHE:000683
|
$3.00 Billion |
|
Redwood Trust, Inc.
NYSE:RWTP
|
$3.00 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MediPal Holdings Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 600,349,000,000 to 619,564,000,000, a change of 19,215,000,000 (3.2%).
- Net income of 40,279,000,000 contributed positively to equity growth.
- Dividend payments of 12,539,000,000 reduced retained earnings.
- Share repurchases of 5,070,000,000 reduced equity.
- Other comprehensive income decreased equity by 3,804,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $40.28 Billion | +6.5% |
| Dividends Paid | $12.54 Billion | -2.02% |
| Share Repurchases | $5.07 Billion | -0.82% |
| Other Comprehensive Income | $-3.80 Billion | -0.61% |
| Other Changes | $349.00 Million | +0.06% |
| Total Change | $- | 3.20% |
Book Value vs Market Value Analysis
This analysis compares MediPal Holdings Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-03-31 | $834.42 | $16.80 | x |
| 2006-03-31 | $1095.87 | $16.80 | x |
| 2007-03-31 | $1124.67 | $16.80 | x |
| 2008-03-31 | $1239.58 | $16.80 | x |
| 2009-03-31 | $1229.32 | $16.80 | x |
| 2010-03-31 | $1230.01 | $16.80 | x |
| 2011-03-31 | $1275.94 | $16.80 | x |
| 2012-03-31 | $1320.55 | $16.80 | x |
| 2013-03-31 | $1424.78 | $16.80 | x |
| 2014-03-31 | $1530.26 | $16.80 | x |
| 2015-03-31 | $1724.47 | $16.80 | x |
| 2016-03-31 | $1832.44 | $16.80 | x |
| 2017-03-31 | $1950.24 | $16.80 | x |
| 2018-03-31 | $2089.03 | $16.80 | x |
| 2019-03-31 | $2099.07 | $16.80 | x |
| 2020-03-31 | $2184.59 | $16.80 | x |
| 2021-03-31 | $2344.69 | $16.80 | x |
| 2022-03-31 | $2376.73 | $16.80 | x |
| 2023-03-31 | $2594.72 | $16.80 | x |
| 2024-03-31 | $2834.70 | $16.80 | x |
| 2025-03-31 | $2971.77 | $16.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MediPal Holdings Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.50%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.10%
- • Asset Turnover: 2.01x
- • Equity Multiplier: 2.95x
- Recent ROE (6.50%) is above the historical average (5.96%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 5.22% | 0.52% | 1.96x | 5.07x | $-8.01 Billion |
| 2006 | 8.60% | 1.08% | 1.93x | 4.10x | $-3.40 Billion |
| 2007 | 7.32% | 0.88% | 2.10x | 3.96x | $-7.01 Billion |
| 2008 | 9.56% | 1.23% | 2.04x | 3.80x | $-1.27 Billion |
| 2009 | 4.25% | 0.51% | 2.21x | 3.79x | $-16.94 Billion |
| 2010 | 0.68% | 0.08% | 2.18x | 4.02x | $-27.04 Billion |
| 2011 | 0.57% | 0.06% | 2.07x | 4.29x | $-28.22 Billion |
| 2012 | 3.76% | 0.42% | 2.16x | 4.11x | $-19.37 Billion |
| 2013 | 5.77% | 0.66% | 2.12x | 4.11x | $-13.67 Billion |
| 2014 | 7.37% | 0.86% | 2.10x | 4.05x | $-9.10 Billion |
| 2015 | 6.07% | 0.82% | 1.97x | 3.73x | $-15.32 Billion |
| 2016 | 7.42% | 1.02% | 2.02x | 3.61x | $-10.72 Billion |
| 2017 | 6.57% | 0.95% | 2.01x | 3.46x | $-15.15 Billion |
| 2018 | 7.18% | 1.11% | 1.94x | 3.35x | $-13.69 Billion |
| 2019 | 6.91% | 1.08% | 1.97x | 3.26x | $-15.33 Billion |
| 2020 | 7.59% | 1.17% | 1.98x | 3.29x | $-12.06 Billion |
| 2021 | 4.57% | 0.75% | 1.91x | 3.21x | $-28.38 Billion |
| 2022 | 5.55% | 0.89% | 1.93x | 3.22x | $-23.61 Billion |
| 2023 | 6.91% | 1.15% | 1.97x | 3.04x | $-17.33 Billion |
| 2024 | 6.91% | 1.17% | 1.98x | 3.00x | $-18.56 Billion |
| 2025 | 6.50% | 1.10% | 2.01x | 2.95x | $-21.68 Billion |
Industry Comparison
This section compares MediPal Holdings Corporation's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,795,116,523
- Average return on equity (ROE) among peers: 10.69%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MediPal Holdings Corporation (MEPDF) | $766.14 Billion | 5.22% | 1.49x | $3.01 Billion |
| Accendra Health Inc (ACH) | $1.03 Billion | 10.82% | 1.27x | $24.00K |
| Arjo AB (publ) (ARRJF) | $9.30 Billion | 0.00% | 0.42x | $491.29 Million |
| Cardinal Health Inc (CAH) | $6.40 Billion | 18.22% | 3.07x | $51.10 Billion |
| Cencora Inc. (COR) | $166.30 Million | 40.59% | 11.39x | $64.39 Billion |
| Cosmos Health Inc. (COSM) | $-4.16 Million | 0.00% | 0.00x | $8.90 Million |
| EDAP TMS SA (EDAP) | $12.58 Million | -61.74% | 2.21x | $112.87 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $1.41 Million | 82.70% | 1.73x | $9.16 Million |
| Energy Management International Inc (ENMI) | $-365.00K | 0.00% | 0.00x | $383.13K |
| Exlites Holdings International Inc (EXHI) | $-126.29 | 0.00% | 0.00x | $574.58K |
| Galenica AG (GALNF) | $1.05 Billion | 16.35% | 1.14x | $3.75 Billion |